Researchers found that heart failure patients without insurance were less likely to receive evidence-based beta-blockers, implantable cardioverter-defibrillator or anticoagulation for atrial fibrillation compared to patients with private insurance. The Medicaid group was also less likely to receive the beta-blockers or defibrillators, and Medicare patients were less likely to receive certain beta-blockers. All three groups had longer hospital stays than the private insurance group.
Related Articles on Hospital Cardiology:
Oregon’s Salem Hospital, Five Medical Groups Create Heart & Vascular Institute
Oklahoma State University Medical Center Offers Mobile Cardiology Unit
Florida’s Sacred Heart Health System to Form System-Based Cardiology Group
